A scoping review of neuromodulation techniques for controlling blood pressure: what are the ups and downs to this approach?

ABSTRACT:

Background and objectives

While there has been rapid progress in research aimed at developing device-based neuromodulation therapies for blood pressure (BP) disorders, there is a paucity of FDA-approved therapies. Currently, the only approved devices for treating resistant hypertension use renal denervation, however, this could soon change as clinical research progresses. With the evolution of interventional strategies for BP regulation, it is important to comprehend the developments to date in order to gauge directions for future research. The objective of this scoping review was to provide the current range of device-based BP neuromodulation approaches, overview salient characteristics of the included studies, address limitations, and detail avenues of further investigation.

M

SUBMITTER: Greechan PL 

PROVIDER: S-EPMC12355777 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature